Abstract| Volume 23, ISSUE 10, SUPPLEMENT , S28, October 2017

Combination of D-Dimer and High-Sensitivity C-Reactive Protein Predicts 30-day Mortality in Atrial Fibrillation Patients Hospitalized for Worsening Heart Failure

      We prospectively investigated the predictive value of D-dimer and high-sensitivity C-reactive protein (hsCRP) for 30-day mortality in 644 paroxysmal or persistent atrial fibrillation patients (mean age of 76 yrs) hospitalized for worsening heart failure. Results: Forty-nine deaths occurred during 30 days. Non-survivors were older (80 vs. 76 yrs, P = .04), had a higher prevalence of NYHA class 4 (71 vs. 39%, P < .0001), higher N-terminal pro-B-type natriuretic peptide levels (8104 vs. 3922 pg/mL, P < .0001), D-dimer (3.10 vs. 1.30 µg/mL, P < .0001), and hsCRP (15.6 vs. 4.88 mg/L, P < .0001) compared with survivors. Multivariate analysis revealed that D-dimer and hsCRP were independently associated with deaths. 30-day mortality rates according to the combination of D-dimer and hsCRP tertiles were shown in Figure. Conclusion: The combination of D-dimer and hsCRP may predict 30-day mortality in this population.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect